Literature DB >> 808728

Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.

A G Vagenakis, L E Braverman, F Azizi, G I Portinay, S H Ingbar.   

Abstract

The pattern of thyrotropin secretion was analyzed in seven euthyroid women, before and after withdrawal of long-term thyroid hormone, by serial measurements of thyroid 131l uptake, serum thyroxine, tri-iodothyronine, and thyrotropin concentrations, and the response to thyrotropin-releasing hormone. During exogenous hormone administration, 131l uptake was suppressed, and serum thyrotropin concentrations before and after administration of thyrotropin-releasing hormone were undetectable. After withdrawal of exogenous hormone, thyrotropin secretory function was transiently impaired, as indicated by undetectable basal thyrotropin concentrations together with absence of response to thyrotropin-releasing hormone, and subsequently by normal values of basal thyrotropin concentration and normal responses to releasing hormone while serum thyroxine and tri-iodothyronine concentrations were subnormal. Decreased thyrotropin reserve persisted for two to five weeks. Detectable values of serum thyrotropin (less than 1.2 muU per milliliter) and a normal 131l uptake usually occurred concurrently in two to three weeks. Serum thyroxine concentration returned to normal at least four weeks after hormone withdrawal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808728     DOI: 10.1056/NEJM197510022931402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  16 in total

1.  Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

Authors:  B A Lamberg; A Aro; P Saarinen; T Tötterman; T Mäkinen
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Nodular goiter: effects of surgery and thyroxine medication.

Authors:  K Westermark; C P Persson; H Johansson; F A Karlsson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  Plummer's disease: localized thyroid autonomy.

Authors:  J D Wiener
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

4.  Finnish national screening for hypothyroidism. Few false positives, early therapy.

Authors:  M Virtanen; J Perheentupa; J Mäenpää; L Pitkänen; J Pikkarainen
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

5.  Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronine.

Authors:  B Busnardo; F Bui; M E Girelli
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

6.  Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.

Authors:  J L Vandalem; G Pirens; G Hennen
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

7.  Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of an optimal saturation regimen with thyroxine or triiodothyronine.

Authors:  B Busnardo; F Bui; M E Girelli
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

8.  Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism.

Authors:  S Fischer; D Flentje; C Kettelhack; J Schmidt-Gayk; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

9.  Isolated thyrotropin deficiency due to a pituitary tumour.

Authors:  H B Lee; C Faiman
Journal:  Can Med Assoc J       Date:  1977-03-05       Impact factor: 8.262

10.  Acute withdrawal of short-term or prolonged L-triiodothyronine administration to thyroidectomized rats results in similar rapid increases in TSH beta mRNA.

Authors:  D S Ross; A Cohen
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.